Nothing Special   »   [go: up one dir, main page]

Nasr et al., 2021 - Google Patents

Bioavailability and antidiabetic activity of gliclazide-loaded cubosomal nanoparticles

Nasr et al., 2021

View HTML
Document ID
9525712416003794201
Author
Nasr M
Almawash S
Al Saqr A
Bazeed A
Saber S
Elagamy H
Publication year
Publication venue
Pharmaceuticals

External Links

Snippet

In this study, gliclazide-loaded cubosomal particles were prepared for improving the oral bioavailability and antidiabetic activity of gliclazide. Four formulations of gliclazide-loaded cubosomal nanoparticles dispersions were prepared by the emulsification method using …
Continue reading at www.mdpi.com (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

Similar Documents

Publication Publication Date Title
Babos et al. Dual drug delivery of sorafenib and doxorubicin from PLGA and PEG-PLGA polymeric nanoparticles
Umerska et al. Polymeric nanoparticles for increasing oral bioavailability of curcumin
Lomis et al. Human serum albumin nanoparticles for use in cancer drug delivery: process optimization and in vitro characterization
Luo et al. Dual pH/redox-responsive mixed polymeric micelles for anticancer drug delivery and controlled release
Halayqa et al. PLGA biodegradable nanoparticles containing perphenazine or chlorpromazine hydrochloride: effect of formulation and release
Ong et al. Influence of the encapsulation efficiency and size of liposome on the oral bioavailability of griseofulvin-loaded liposomes
Souto et al. Nanopharmaceutics: Part II—Production scales and clinically compliant production methods
Nasr et al. Bioavailability and antidiabetic activity of gliclazide-loaded cubosomal nanoparticles
Ding et al. Enhanced oral bioavailability of celecoxib nanocrystalline solid dispersion based on wet media milling technique: formulation, optimization and in vitro/in vivo evaluation
Sreeharsha et al. Development of metronidazole loaded chitosan nanoparticles using QbD approach—A novel and potential antibacterial formulation
Xu et al. Development of hydrophilic drug encapsulation and controlled release using a modified nanoprecipitation method
Kohli et al. Development of natural polysaccharide–based nanoparticles of berberine to enhance oral bioavailability: Formulation, optimization, ex vivo, and in vivo assessment
Lee et al. Preparation of temozolomide-loaded nanoparticles for glioblastoma multiforme targeting—ideal versus reality
Marslin et al. Solid lipid nanoparticles of albendazole for enhancing cellular uptake and cytotoxicity against U-87 MG glioma cell lines
Kolluru et al. Characterization and applications of colloidal systems as versatile drug delivery carriers for parenteral formulations
Suresh et al. Development of a novel methotrexate-loaded nanoemulsion for rheumatoid arthritis treatment with site-specific targeting subcutaneous delivery
Kalombo et al. Spray-dried, nanoencapsulated, multi-drug anti-tuberculosis therapy aimed at once weekly administration for the duration of treatment
Saraogi et al. Formulation development and evaluation of pravastatin-loaded nanogel for hyperlipidemia management
Goudon et al. Controlled release of retinol in cationic co-polymeric nanoparticles for topical application
Ajiboye et al. Olanzapine loaded nanostructured lipid carriers via high shear homogenization and ultrasonication
Shrestha et al. Tailoring midazolam-loaded chitosan nanoparticulate formulation for enhanced brain delivery via intranasal route
Zafar et al. Development and optimization of nanolipid-based formulation of diclofenac sodium: in vitro characterization and preclinical evaluation
Awan et al. Nanocrytals-mediated oral drug delivery: enhanced bioavailability of amiodarone
Fule et al. Formulation, Optimization and Evaluation of Cytarabine-Loaded Iron Oxide Nanoparticles: From In Vitro to In Vivo Evaluation of Anticancer Activity
Mira et al. Physico-chemically distinct nanomaterials synthesized from derivates of a poly (anhydride) diversify the spectrum of loadable antibiotics